Logo for Lophos Holdings Inc.

Lophos Holdings Inc.

Issued & Outstanding85,859,673
Reserved for Issuance24,197,922
CSE Index


Lophos Holdings Inc.

Listing date
September 06, 2023

Lophos Holdings Inc. pertains to the cultivation and research of Lophophora williamsii (“peyote cactus”). Additionally, in the long-term, the Company is engaged in the research and development of compounds derived from peyote cactus. The company’s wholly-owned subsidiary, Lophos Pharmaceuticals Corp., is a biosciences company that specializes in peyote cactus cultivation, research, and sale. It is also licensed to possess, produce, sell/provide, send, transport and deliver the controlled substances covered by its Controlled Substances Dealers License (CSDL), namely mescaline, psilocin and psilocybin.